# Non-Anion Gap Metabolic Acidosis

A practical workup for hyperchloremic metabolic acidosis: confirm the acid-base disorder, identify gastrointestinal versus renal bicarbonate loss, use potassium and urinary ammonium surrogates appropriately, and recognize renal tubular acidosis, kidney dysfunction, urinary diversion, and chloride-rich fluid exposure.

**Clinical question:** How should physicians differentiate gastrointestinal bicarbonate loss, renal tubular acidosis, kidney dysfunction, and iatrogenic causes of non-anion gap metabolic acidosis?

Updated: 2026-09-15T18:01:01.675009+00:00

## What matters in practice
- Confirm metabolic acidosis with blood gas pH and low serum bicarbonate, then calculate anion gap as sodium minus chloride plus bicarbonate; a normal gap with reciprocal hyperchloremia defines the working phenotype. [1][17][19]
- In established hyperchloremic metabolic acidosis, a negative urine anion gap supports appropriate renal ammonium excretion and favors extrarenal bicarbonate loss; a positive value favors impaired ammonium production or distal acidification. [5][13]
- Use serum potassium early: low or low-normal potassium narrows the differential toward gastrointestinal loss, proximal RTA, or distal RTA, whereas high or high-normal potassium prioritizes type 4 RTA and reduced renal acid excretion. [3][5]
- Do not diagnose RTA from urine pH alone. Urine pH is potentially misleading, and urine anion gap interpretation is limited in acute hyperchloremic acidosis, CKD, and bicarbonaturia with urine pH above 6.5. [1][5]
- Review recent chloride-rich fluid exposure, including large-volume 0.9% saline, because it can cause hyperchloremic non-anion gap acidosis; consider balanced crystalloids when ongoing substantial crystalloid resuscitation is needed and traumatic brain injury is absent. [12][22]

## Confirm the disorder and identify immediate threats

Do not interpret a low chemistry-panel total CO2 as isolated RTA before confirming the acid-base process.

Obtain a venous or arterial blood gas when the clinical setting permits confirmation of acidemia and respiratory compensation. Metabolic acidemia is present when plasma pH is below 7.35 with a primary reduction in bicarbonate; a low serum total CO2 alone can be misclassified when a mixed acid-base disorder is present. [17][24]

Calculate the serum anion gap: AG = serum sodium − (chloride + bicarbonate). A normal-gap pattern occurs when the fall in bicarbonate is balanced by chloride retention, producing hyperchloremic metabolic acidosis. Renal insufficiency can produce either high-gap or non-gap acidosis, so an apparently normal gap does not exclude clinically important kidney dysfunction. [1][19][21]

Correct the calculated anion gap for hypoalbuminemia before classifying a low-bicarbonate state as pure non-gap acidosis: add 2.5 mmol/L to the measured AG for each 1 g/dL that albumin is below normal. An increased corrected AG should redirect the workup toward concurrent lactate, ketones, uremic acids, or toxins rather than a stand-alone non-gap algorithm. [24][6]

Treat instability while the cause is being defined. Acute metabolic acidosis can reduce cardiac output, promote arterial vasodilation and hypotension, impair oxygen delivery, reduce ATP production, and predispose to arrhythmias; identify and reverse the responsible process rather than reflexively treating the bicarbonate value alone. Base administration in acute metabolic acidosis remains controversial because definitive benefit is uncertain and complications may occur. [1]
- Send at presentation: repeat basic metabolic panel, blood gas, albumin, creatinine, potassium, chloride, and glucose; add lactate and ketone testing when the corrected AG is elevated or the history suggests mixed acidosis. [1][21][23][24]
- If the AG is elevated despite hyperchloremia, assess the delta relationship between AG rise and bicarbonate fall for a superimposed metabolic alkalosis or additional metabolic acidosis. [24]
- With diabetes or SGLT2-inhibitor exposure, check plasma ketones even if glucose is less than 250 mg/dL; euglycemic DKA retains high-gap acidosis and increased ketones. [23]

*Initial classification changes the next diagnostic branch. [1][19][21][24]*

| Finding | Interpretation | Next action |
| --- | --- | --- |
| Low bicarbonate with pH below 7.35 [17] | Metabolic acidemia requires etiologic classification. [17] | Calculate AG and correct for albumin. [1][24] |
| Normal corrected AG with hyperchloremia [1][19] | Non-anion gap metabolic acidosis is likely. [1][19] | Review gastrointestinal loss, urinary diversion, medications/fluids, kidney function, potassium, and urine indices. [3][5][11][22] |
| Elevated corrected AG [24] | Concurrent organic acid, ketoacid, uremic acid, or toxin-related process is possible. [6][21][23][24] | Measure lactate and ketones; evaluate renal function and exposure history before labeling the process NAGMA. [6][21][23] |
| Low bicarbonate with discordant pH or compensation [24] | Mixed respiratory or metabolic disorder may be present. [24] | Interpret blood gas and AG/delta relationship before pursuing RTA testing. [24] |

## Use exposure history and potassium to separate major causes

The highest-yield distinction is extrarenal alkali loss or chloride gain versus impaired renal acid excretion.

Ask specifically about diarrhea, high-output ileostomy, and prior bowel surgery. High-volume ileostomy output can cause large bicarbonate losses and non-gap metabolic acidosis; diarrhea is the prototypical extrarenal cause that should generate an appropriately increased renal ammonium response. [3][5]

Review all recent fluids and infusions. Excess chloride delivery from 0.9% saline and other chloride-containing infusions can produce hyperchloremic acidosis; large-volume normal saline is also associated with worsening renal function. When continued substantial crystalloid resuscitation is required, balanced crystalloids are reasonable alternatives in many critically ill patients, while traumatic brain injury is a major exception cited for avoiding lactated Ringer's. [12][22]

Ask about urinary reconstruction. An ileal neobladder is an important cause of non-anion gap acidosis and should move urinary diversion high in the differential before a renal tubular defect is assigned. [11]

Stratify with serum potassium after confirming NAGMA. Low or low-normal potassium is the usual branch for gastrointestinal bicarbonate loss and type 1 or type 2 RTA; high or high-normal potassium points toward type 4 RTA or another state of impaired ammonium production/excretion. This potassium-first split is a practical way to prioritize urine testing and medication review. [3][5]

Assess kidney function concurrently. CKD can blunt ammonium excretion irrespective of the primary disorder, making an impaired renal ammonium response less specific for a primary tubular disorder. Do not interpret a positive urine anion gap as diagnostic of RTA without considering reduced GFR and the overall clinical setting. [5][19][21]
- Low potassium branch: diarrhea or ostomy losses; proximal RTA; distal RTA. [3][5]
- High potassium branch: type 4 RTA or reduced renal ammonium excretion, particularly when kidney dysfunction is present. [3][5]
- Exposure branch: recent high-volume saline or chloride-containing infusion; ileal urinary diversion. [11][12][22]

*History and potassium identify the most useful urine-testing pathway. [3][5][11][12][22]*

| Clinical pattern | Most likely etiologic branch | Immediate discriminator |
| --- | --- | --- |
| Diarrhea or high-output ileostomy with low/low-normal potassium [3][5] | Extrarenal bicarbonate loss. [3][5] | Check urine anion gap for an appropriate ammonium response; negative UAG supports this branch. [5] |
| Large-volume 0.9% saline or chloride-containing infusion [12][22] | Iatrogenic chloride-associated acidosis. [12][22] | Stop unnecessary chloride loading and reassess chloride, bicarbonate, renal function, and resuscitation fluid choice. [12][22] |
| Ileal neobladder or urinary diversion [11] | Urinary diversion-associated NAGMA. [11] | Identify the diversion as the likely exposure before attributing the pattern to primary RTA. [11] |
| Hyperkalemia or high-normal potassium [3][5] | Type 4 RTA or impaired renal ammonium excretion. [3][5] | Review kidney function and medications/exposures that can reduce aldosterone effect or ammonium excretion. [5] |
| Recurrent nephrolithiasis with persistent NAGMA [8] | Distal RTA, including inherited disease. [8][13] | Obtain urine acidification indices and consider molecular evaluation when hereditary features are present. [8] |

## Estimate renal ammonium excretion before diagnosing RTA

Urine anion gap is a surrogate for ammonium excretion, not a stand-alone diagnostic test.

In persistent, established hyperchloremic metabolic acidosis, calculate urine anion gap (UAG) as urine sodium + urine potassium − urine chloride. A negative UAG supports high urinary ammonium excretion and an appropriate renal response, favoring extrarenal bicarbonate loss such as diarrhea. A positive UAG supports reduced ammonium excretion and favors distal RTA or type 4 RTA. [5][13]

Interpret a negative UAG cautiously. It does not exclude proximal (type 2) RTA, in which the UAG can be negative despite a renal cause of acidosis. Therefore, a patient with low potassium, persistent NAGMA, and a negative UAG still requires consideration of proximal bicarbonate wasting when the clinical phenotype does not fit gastrointestinal loss. [5]

Do not rely on UAG in acute hyperchloremic metabolic acidosis. Its utility is also limited in CKD, where ammonium excretion may be reduced regardless of the primary lesion, and when urine pH exceeds 6.5, because urinary bicarbonate becomes a meaningful unmeasured anion that is omitted from the UAG calculation. [5]

Use urine pH as a contextual discriminator rather than proof of distal RTA. The classic distal RTA phenotype includes hyperchloremic metabolic acidosis, diminished net acid excretion, positive UAG, and urine pH greater than 6; however, urine pH can be misleading in hyperchloremic acidosis. Persistent inappropriately alkaline urine is most useful when it agrees with reduced ammonium excretion and the clinical phenotype. [1][13]
- Negative UAG: favors appropriate ammonium excretion and extrarenal bicarbonate loss, but does not rule out proximal RTA. [5]
- Positive UAG: favors defective distal hydrogen secretion or impaired ammonium production/excretion; distinguish distal RTA from type 4 RTA with serum potassium and kidney context. [5][13]
- Urine pH greater than 6.5: UAG becomes less reliable because bicarbonate is not included in the calculation. [5]

### When urine indices should change the next step

A negative UAG with a clear history of diarrhea, ostomy output, or other gastrointestinal loss supports an extrarenal source; direct management toward volume, electrolyte, and ongoing loss replacement rather than an RTA workup. [3][5]

A positive UAG with low potassium and persistently alkaline urine raises distal RTA; recurrent stones, growth impairment, or long-standing unexplained NAGMA increase concern for inherited disease and support timely molecular testing, including SLC4A4 and ATP6V1B1 in the described hereditary context. [8][13]

A positive UAG with hyperkalemia or high-normal potassium favors type 4 RTA or impaired ammonium generation/excretion. Identify kidney dysfunction and review the clinical context before interpreting this as an isolated collecting-duct disorder. [3][5]

*Interpret urine indices only after NAGMA is confirmed and major confounders are considered. [5][13]*

| Urine finding | Interpretation in established NAGMA | Important limitation |
| --- | --- | --- |
| Negative UAG [5] | Appropriate ammonium excretion; favors gastrointestinal bicarbonate loss. [5] | May also occur in proximal RTA. [5] |
| Positive UAG [5][13] | Reduced ammonium excretion; favors distal RTA or type 4 RTA. [5][13] | CKD can reduce ammonium excretion independent of primary RTA. [5] |
| Urine pH >6 with positive UAG [13] | Supports the classic distal RTA pattern when systemic acidosis is present. [13] | Urine pH alone is potentially misleading. [1] |
| Urine pH >6.5 [5] | Bicarbonaturia may be present. [5] | UAG omits urinary bicarbonate and has limited value. [5] |

## Recognize renal tubular acidosis patterns without overcalling them

RTA is a diagnosis of persistent hyperchloremic metabolic acidosis with an inappropriately limited renal acid response after mimics are addressed.

Distal (type 1) RTA reflects impaired distal hydrogen secretion in the setting of systemic acidosis. The practical phenotype is persistent NAGMA with reduced net acid excretion, positive UAG, and urine pH typically greater than 6; renal potassium wasting and recurrent nephrolithiasis strengthen the diagnosis. [8][13]

Proximal (type 2) RTA is a bicarbonate-reabsorption disorder and cannot be excluded by a negative UAG. In a low-potassium patient with persistent NAGMA, no convincing gastrointestinal loss, and a negative UAG, retain proximal RTA in the differential rather than treating the urine result as proof of a nonrenal cause. [5]

Type 4 RTA should be prioritized when NAGMA coexists with hyperkalemia or high-normal potassium. The expected urine pattern is impaired ammonium production/excretion, which may yield a positive UAG; distinguish this from reduced ammonium excretion due to CKD by integrating renal function and the broader clinical context. [3][5]

Escalate beyond routine urine indices when inherited distal RTA is plausible. Recurrent nephrolithiasis, unexplained growth failure, or persistent NAGMA are features that should prompt early consideration of molecular testing; the reported hereditary evaluation includes SLC4A4 and ATP6V1B1. [8]
- Distal RTA: low potassium, positive UAG, limited net acid excretion, urine pH typically greater than 6, and stones favor the diagnosis. [8][13]
- Proximal RTA: do not exclude solely because UAG is negative. [5]
- Type 4 RTA: high/high-normal potassium plus impaired ammonium excretion pattern; assess kidney function as a confounder. [3][5]

*Renal tubular patterns are interpreted within confirmed persistent NAGMA. [3][5][8][13]*

| Pattern | Potassium tendency | Urine findings | Clinical discriminator |
| --- | --- | --- | --- |
| Distal (type 1) RTA [8][13] | Renal potassium wasting may occur. [13] | Positive UAG and urine pH >6 with reduced net acid excretion. [13] | Recurrent nephrolithiasis or persistent unexplained NAGMA supports the diagnosis. [8] |
| Proximal (type 2) RTA [5] | Low/low-normal potassium branch. [3][5] | UAG can be negative. [5] | Do not mistake negative UAG for proof of gastrointestinal loss. [5] |
| Type 4 RTA [3][5] | High/high-normal potassium. [3][5] | Positive UAG may reflect impaired ammonium production/excretion. [5] | Assess for CKD and other causes of reduced ammonium excretion. [5] |

## Reverse the driver and monitor the biochemical response

Management is cause-directed; bicarbonate correction should not substitute for identifying the acid-base mechanism.

For gastrointestinal bicarbonate loss, quantify and control ongoing stool or ostomy output, restore volume and electrolytes, and follow serial bicarbonate, chloride, potassium, and creatinine. A negative UAG supports that the kidney is responding appropriately; persistent acidosis despite loss control should trigger reassessment for a renal or mixed process. [3][5]

For chloride-associated acidosis, discontinue unnecessary chloride-rich infusions and reassess the resuscitation strategy. Large-volume normal saline can cause hyperchloremic NAGMA, whereas balanced crystalloids are at least as effective or modestly favorable for mortality and kidney outcomes in some high-volume, critically ill settings; traumatic brain injury is the cited major exception to lactated Ringer's use. [12][22]

For suspected RTA, establish the subtype before committing to long-term alkali treatment. Chronic metabolic acidosis contributes to muscle degradation and abnormal bone metabolism, and chronic alkali administration is distinguished from acute bicarbonate use by a more favorable treatment rationale; patients with inherited distal RTA benefit from early alkali therapy in the reported clinical literature. [1][8]

Monitor response with serial serum bicarbonate, chloride, potassium, and creatinine, plus reassessment of urine indices only after the acute state and major confounders have resolved. A persistently positive UAG or alkaline urine during active bicarbonaturia, acute hyperchloremia, or CKD should not be used alone to escalate to a definitive RTA label. [5]
- Recheck the basic metabolic panel after changing fluid composition, controlling gastrointestinal losses, or initiating cause-directed therapy; falling chloride and rising bicarbonate support correction of the non-gap process. [1][12][22]
- Use alkali in chronic acidosis as part of cause-directed care; avoid treating an acute bicarbonate value in isolation when the underlying shock, ketoacidosis, toxin exposure, or renal failure has not been addressed. [1][6]
- Seek nephrology input for persistent unexplained NAGMA, suspected inherited RTA, recurrent nephrolithiasis with distal RTA phenotype, or an equivocal urine study complicated by CKD. [5][8][13]

*Cause-directed actions follow the etiologic branch rather than the bicarbonate value alone. [1][3][5][12][22]*

| Identified driver | Action | Monitoring target |
| --- | --- | --- |
| Diarrhea or high-output ileostomy [3][5] | Control ongoing gastrointestinal loss and restore volume/electrolytes. [3][5] | Serial bicarbonate, chloride, potassium, creatinine, and clinical loss volume. [3][5] |
| Chloride-rich fluid exposure [12][22] | Stop unnecessary high-chloride fluid and consider balanced crystalloid when clinically appropriate. [12][22] | Chloride, bicarbonate, renal function, and ongoing fluid requirement. [12][22] |
| Distal or inherited RTA phenotype [8][13] | Confirm renal acidification defect; consider molecular testing when hereditary features are present and initiate early alkali-directed care. [8] | Bicarbonate, potassium, kidney function, and stone burden when present. [8][13] |
| CKD-associated limited ammonium excretion [5][19][21] | Interpret urine indices in the context of reduced renal function and evaluate for concurrent gap acidosis. [5][19][21] | Creatinine, bicarbonate, potassium, chloride, and corrected AG. [5][24] |

## References
1. Metabolic acidosis: pathophysiology, diagnosis and management | Nature Reviews Nephrology — www.nature.com — https://www.nature.com/articles/nrneph.2010.33
2. Pyroglutamic acidosis as a cause for high anion gap metabolic acidosis: a prospective study | Scientific Reports — www.nature.com — https://www.nature.com/articles/s41598-019-39257-4
3. Non–Anion Gap Metabolic Acidosis: A Clinical Approach to Evaluation - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S0272638616305157
4. High-anion gap hyperchloremic acidosis mimicking diabetic ketoacidosis on initial presentation – Case report — www.sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S2211419X19301508?dgcid=rss_sd_all#!
5. Approach to Renal Tubular Acidosis – A Review : Indian Journal of Endocrinology and Metabolism — journals.lww.com — https://journals.lww.com/indjem/_layouts/15/oaks.journals/downloadpdf.aspx?an=02223308-202601000-00004
6. Metabolic acidosis in the critically ill: Part 2. Causes and treatment — associationofanaesthetists-publications.onlinelibrary.wiley.com — https://associationofanaesthetists-publications.onlinelibrary.wiley.com/doi/10.1111/j.1365-2044.2007.05371.x
7. Metabolic acidosis due to d-lactate in a patient... : International Journal of Surgery Case Reports — journals.lww.com — https://journals.lww.com/ijscr/_layouts/15/oaks.journals/downloadpdf.aspx?an=01612930-202501000-00150
8. Inherited Type-1 renal tubular acidosis with... : Annals of Medicine & Surgery — journals.lww.com — https://journals.lww.com/annals-of-medicine-and-surgery/_layouts/15/oaks.journals/downloadpdf.aspx?an=01845215-202512000-00158
9. A review of renal tubular acidosis - Wiley Online Library — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/10.1111/vec.13407
10. Clinical utility of anion gap in deciphering acid–base disorders - 2009 — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/10.1111/j.1742-1241.2009.02000.x
11. Ileal Neobladder: An Important Cause of Non-Anion Gap Metabolic Acidosis - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S0736467916312227
12. Successful Rescue of Deep Coma, Shock, and... : Journal of Emergencies, Trauma, and Shock — journals.lww.com — https://journals.lww.com/onlinejets/fulltext/2025/07000/successful_rescue_of_deep_coma,_shock,_and.7.aspx
13. Pseudo-Renal Tubular Acidosis: Conditions Mimicking Renal Tubular Acidosis - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S1548559518300855
14. Demystifying normal‐anion‐gap metabolic acidosis ... — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/full/10.1111/imj.16418
15. Effect of Intravenously Administered Crystalloid Solutions on Acidâ — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvim.14803
16. Anions and the anaesthetist - Maloney - 2002 - Anaesthesia — associationofanaesthetists-publications.onlinelibrary.wiley.com — https://associationofanaesthetists-publications.onlinelibrary.wiley.com/doi/10.1046/j.1365-2044.2002.02274.x
17. Metabolic acidosis in the critically ill: Part 1. Classification and ... — associationofanaesthetists-publications.onlinelibrary.wiley.com — https://associationofanaesthetists-publications.onlinelibrary.wiley.com/doi/10.1111/j.1365-2044.2007.05370.x
18. Renal tubular acidosis in a mule mare - 2026 - Wiley Online Library — beva.onlinelibrary.wiley.com — https://beva.onlinelibrary.wiley.com/doi/10.1111/eve.14178
19. Anion Gap and Non-Anion Gap Metabolic Acidosis - PubMed — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/pubmed/28846305
20. Hyperchloremic acidosis (Concept Id: C0085569)
 - MedGen - NCBI — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/medgen/43207
21. Anion Gap and Non-Anion Gap Metabolic Acidosis - StatPearls - NCBI Bookshelf — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/books/NBK448090?report=reader
22. Updated Considerations for Intravenous Fluid Resuscitation | Critical Care Medicine Section — www.acep.org — https://www.acep.org/criticalcare/newsroom/newsroom-articles/december-2024/updated-considerations-for-intravenous-fluid-resuscitation
23. Classic diabetic ketoacidosis and the euglycemic variant — www.ccjm.org — https://www.ccjm.org/content/92/1/33
24. A patient with altered mental status and an acid-base disturbance | Cleveland Clinic Journal of medicine — www.ccjm.org — https://www.ccjm.org/content/84/1/27

## Editorial note

Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.